Radient Technologies Inc. Stock price

Equities

RTI.H

CA75034P1062

Pharmaceuticals

Delayed Toronto S.E. 03:56:03 2023-03-07 pm EST 5-day change 1st Jan Change
0.005 CAD -.--% Intraday chart for Radient Technologies Inc. -.--% -.--%
Sales 2021 2.49M 1.84M Sales 2022 3.62M 2.67M Capitalization 29.2M 21.54M
Net income 2021 -42M -30.99M Net income 2022 -12M -8.85M EV / Sales 2021 21.6 x
Net Debt 2021 11.44M 8.44M Net Debt 2022 13.67M 10.09M EV / Sales 2022 11.8 x
P/E ratio 2021
-0.85 x
P/E ratio 2022
-1.93 x
Employees 33
Yield 2021 *
-
Yield 2022
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Radient Technologies Inc. Announces the Resignation of Interim Chairman Jocelyne Lafreniere from its Board of Directors CI
Radient Technologies Inc. announced that it has received CAD 0.4 million in funding CI
Radient Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Radient Technologies Inc. Appoints Steven Splinter as Interim CEO CI
Radient Technologies Inc. Appoints Dimitris Tzanis as Director CI
Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in funding CI
Radient Technologies Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Radient Technologies Inc. Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Radient Technologies Inc. Auditor Raises 'Going Concern' Doubt CI
Radient Technologies Inc. Announces Board Changes CI
Radient Technologies Inc. cancelled the acquisition of PBR Laboratories Inc. CI
Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in funding CI
Radient Technologies Inc. Amends Loan Facility as Part of Restructuring Plan CI
Radient Technologies Inc. announced that it expects to receive CAD 9.93 million in funding from Moskowitz Capital Mortgage Fund II Inc. CI
Radient Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
More news
3 years
0.01
Extreme 0.005
0.12
5 years
0.01
Extreme 0.005
1.09
10 years
0.01
Extreme 0.005
2.28
More quotes
Managers TitleAgeSince
Founder - 01-06-11
Director of Finance/CFO - 14-05-21
Chief Operating Officer - -
Members of the board TitleAgeSince
Director of Finance/CFO - 14-05-21
Founder - 01-06-11
Director/Board Member 51 16-12-22
More insiders
Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles.
More about the company
  1. Stock
  2. Equities
  3. Stock Radient Technologies Inc. - Toronto S.E.